Effectiveness and Safety of Antiobesity Medications in Patients With Obesity and Inflammatory Bowel Disease

被引：3
|
作者：
Pham, Jonathan T. [1 ]
Ghusn, Wissam [2 ,3 ]
Acosta, Andres [2 ,3 ]
Loftus, Edward V. [2 ]
Johnson, Amanda M. [2 ]
机构：
[1] Mayo Clin, Coll Med & Sci, Dept Internal Med, Rochester, MN USA
[2] Mayo Clin, Coll Med & Sci, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[3] Mayo Clin, Coll Med & Sci, Precis Med Obes Program, Rochester, MN USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 06期
关键词：
inflammatory bowel disease; obesity; Crohn's disease; ulcerative colitis; antiobesity medications; CEREBROVASCULAR ACCIDENTS; RISK;
D O I：
10.14309/ajg.0000000000002490
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
INTRODUCTION: Limited data exist evaluating antiobesity medications (AOM) in patients with inflammatory bowel disease (IBD). METHODS: We performed a case-control study evaluating the effectiveness and safety of AOM in patients with IBD with obesity, matched to non-IBD controls. RESULTS: After 12 months, the case (n = 36) and control (n = 36) groups achieved similar percent total body weight loss of -6.9 +/- 8.3 and -8.1 +/- 7.0 (P = 0.30), respectively. Side effect profiles were similar between groups. Seven patients experienced an IBD flare, all managed medically. DISCUSSION: AOM use in patients with IBD demonstrated similar effectiveness and safety when compared with that observed in the non-IBD population.
引用
收藏
页码：1197 / 1200
页数：4
相关论文
共 50 条
  • [1] Effectiveness and Safety of Semaglutide for Weight Loss in Patients With Inflammatory Bowel Disease and Obesity
    Desai, Aakash
    Khataniar, Himsikhar
    Hashash, Jana G.
    Farraye, Francis A.
    Regueiro, Miguel
    Kochhar, Gursimran S.
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [2] EFFICACY AND SAFETY OF SEMAGLUTIDE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND OBESITY
    Desai, Aakash
    Khataniar, Himsikhar
    Hashash, Jana G.
    Farraye, Francis A.
    Regueiro, Miguel D.
    Kochhar, Gursimran S.
    GASTROENTEROLOGY, 2024, 166 (05) : S1454 - S1455
  • [3] Safety and Effectiveness of Vedolizumab in Elderly Patients with Inflammatory Bowel Disease
    Dahiya, Dushyant Singh
    Chandan, Saurabh
    Bapaye, Jay
    Mohan, Babu P.
    Ramai, Daryl
    Kassab, Lena L.
    Chandan, Ojasvini C.
    Dulai, Parambir S.
    Kochhar, Gursimran S.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2024, 58 (04) : 378 - 388
  • [4] Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease
    Amiot, Aurelien
    Grimaud, Jean-Charles
    Peyrin-Biroulet, Laurent
    Filippi, Jerome
    Pariente, Benjamin
    Roblin, Xavier
    Buisson, Anthony
    Stefanescu, Carmen
    Trang-Poisson, Caroline
    Altwegg, Romain
    Marteau, Philippe
    Vaysse, Thibaud
    Bourrier, Anne
    Nancey, Stephane
    Laharie, David
    Allez, Matthieu
    Savoye, Guillaume
    Moreau, Jacques
    Gagniere, Charlotte
    Vuitton, Lucine
    Viennot, Stephanie
    Aubourg, Alexandre
    Pelletier, Anne-Laure
    Bouguen, Guillaume
    Abitbol, Vered
    Bouhnik, Yoram
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (11) : 1593 - +
  • [5] Safety and Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists for Obesity in Patients With Inflammatory Bowel Disease
    Clarke, Lindsay
    Pasam, Ravi Teja
    Jirapinyo, Pichamol
    Allegretti, Jessica R.
    Kelly, Colleen R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1000 - S1001
  • [6] Effectiveness and safety of thioguanine in thiopurine-naive Inflammatory Bowel Disease patients
    Crouwel, F.
    Bayoumy, A. B.
    Mulder, C. J. J.
    Peters, J. H. C.
    Boekema, P. J.
    Derijks, L. J. J.
    De Boer, S. Y.
    van de Meeberg, P. C.
    Ahmad, I.
    Buiter, H. J. C.
    de Boer, N. K.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I529 - I529
  • [7] Effectiveness and safety of thioguanine in thiopurine-naive Inflammatory Bowel Disease patients
    Crouwel, F.
    Bayoumy, A. B.
    Mulder, C. J. J.
    Peters, J. H. C.
    Boekema, P. J.
    Derijks, L. J. J.
    De Boer, S. Y.
    de Meeberg, P. C. van
    Ahmad, I.
    Buiter, H. J. C.
    de Boer, N. K.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I529 - I529
  • [8] Effectiveness and safety of prophylactic anticoagulation among hospitalized patients with inflammatory bowel disease
    Dawwas, Ghadeer K.
    Cuker, Adam
    Schaubel, Douglas E.
    Lewis, James D.
    BLOOD ADVANCES, 2024, 8 (05) : 1272 - 1280
  • [9] THE BENEFITS FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE TAKING ASCVD MEDICATIONS
    不详
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2021, 125 (01): : 117 - 117
  • [10] Racial Disparities in Utilization of Medications in Inflammatory Bowel Disease Patients
    Alchirazi, Khaled Alsabbagh
    Mohammed, Abdul
    Eltelbany, Ahmed
    Albakri, Almaza A.
    Alkhayyat, Motasem
    Abu-Shawer, Osama
    Regueiro, Miguel
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S758 - S759
12345